Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
7.60
-0.01 (-0.13%)
Jan 24, 2025, 4:00 PM EST - Market closed

Cryo-Cell International Revenue

Cryo-Cell International had revenue of $8.07M in the quarter ending August 31, 2024, with 2.50% growth. This brings the company's revenue in the last twelve months to $31.84M, up 1.95% year-over-year. In the fiscal year ending November 30, 2023, Cryo-Cell International had annual revenue of $31.34M with 3.32% growth.

Revenue (ttm)
$31.84M
Revenue Growth
+1.95%
P/S Ratio
1.95
Revenue / Employee
$361,801
Employees
88
Market Cap
61.26M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Nov 30, 202331.34M1.01M3.32%
Nov 30, 202230.34M1.45M5.03%
Nov 30, 202128.88M-2.26M-7.26%
Nov 30, 202031.15M-668.98K-2.10%
Nov 30, 201931.82M2.60M8.89%
Nov 30, 2018 Pro Pro Pro
Nov 30, 2017 Pro Pro Pro
Nov 30, 2016 Pro Pro Pro
Nov 30, 2015 Pro Pro Pro
Nov 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.95B
Revenue Rankings